Helen Lin

Medicine · Health Sciences

19h-index1.1kcitations43works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(5), Health Systems, Economic Evaluations, Quality of Life(4), Prostate Cancer Treatment and Research(3), Cancer, Hypoxia, and Metabolism(3), Trace Elements in Health(3)

Publications43 total

356 Enhancing Bladder Cancer Diagnosis through the Integration of an AI-Driven Cytology System
Laboratory Investigation·2025Open Access
Indirect Costs of Alzheimer’s Disease: Unpaid Caregiver Burden and Patient Productivity Loss
Value in Health·2024· 9 citedOpen Access
Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease
EClinicalMedicine·2024· 11 citedOpen Access
Dissecting components of the <i>Campylobacter jejuni fetMP-fetABCDEF</i> gene cluster under iron limitation
Microbiology Spectrum·2023· 2 citedOpen Access
Dissecting components of the <i>Campylobacter jejuni fetMP-fetABCDEF</i> gene cluster in iron scavenging
2023Open Access
ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer’s Disease (S26.006)
Neurology·2023
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy
Annals of Clinical and Translational Neurology·2022· 34 citedOpen Access
Stimuli Induced Uptake of Protein‐Like Peptide Brush Polymers
Chemistry - A European Journal·2021· 8 citedOpen Access
A copper site is required for iron transport by the periplasmic proteins P19 and FetP
Metallomics·2020· 5 citedOpen Access
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks
Journal of Alzheimer s Disease·2020· 64 citedOpen Access
“If I spent five hours giving birth then I can do this final:” A qualitative investigation of college students with children.
Translational Issues in Psychological Science·2020· 7 cited
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease
Alzheimer s Research & Therapy·2020· 43 citedOpen Access
Experiences of Student-Parents Interview Guide
PsycTESTS Dataset·2020
Fabrication of Curcumin-Loaded Dairy Milks Using the pH-Shift Method: Formation, Stability, and Bioaccessibility
Journal of Agricultural and Food Chemistry·2019· 39 cited
Baseline Characteristics from a Phase III Trial of Crenezumab in Early (Prodromal-to-Mild) Alzheimer’s Disease (CREAD) (P4.1-002)
Neurology·2019· 2 cited
Loading natural emulsions with nutraceuticals using the pH-driven method: formation &amp; stability of curcumin-loaded soybean oil bodies
Food & Function·2019· 50 cited
O1‐02‐04: BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER'S DISEASE (CREAD)
Alzheimer s & Dementia·2018· 2 cited
Intra-Abdominal Varix Rupture: A Life-Threatening Cause of Hemoperitoneum
The American Journal of Medicine·2018· 3 cited
Safety, Tolerability and Pharmacokinetics of Crenezumab in Mild-to-Moderate AD Patients Treated with Escalating Doses for up to 32.3 Months (P6.182)
Neurology·2018· 3 cited
[O2–17–06]: SAFETY AND TOLERABILITY OF CRENEZUMAB IN MILD‐TO‐MODERATE AD PATIENTS TREATED WITH ESCALATING DOSES FOR UP TO 25 MONTHS
Alzheimer s & Dementia·2017· 3 cited
page 1 of 3Next →

Frequent Co-authors

Susanne Ostrowitzki(7), Jillian Smith(6), Angelica Quartino(5), Rachelle S. Doody(4), David K. Ann(3), Kaycee M. Sink(3), Tobias Bittner(3), Beverly Assman(3), Jehonathan H. Pinthus(3), Anson Chan(3), M.E.P. Murphy(3), Michael Rabbia(3), Andres Schneider(3), Steve Huang(2), Yun Yen(2), James R. Connor(2), Bingjing Zheng(2), David Julian McClements(2), Gurmit Singh(2), Eunjoo H. Lee(2)